Immunity, Inflammation and Disease Laboratory, Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27709, USA.
Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA.
Lung. 2020 Apr;198(2):289-298. doi: 10.1007/s00408-020-00337-2. Epub 2020 Feb 14.
Innate immune activation through exposure to indoor and outdoor pollutants is emerging as an important determinant of asthma severity. For example, household levels of the bacterial product lipopolysaccharide (LPS) are associated with increased asthma severity. We hypothesized that activation of the innate immune receptor TLR5 by its bacterial ligand flagellin will exacerbate airway inflammation and asthma symptoms.
We determined the effect of flagellin co-exposure with ovalbumin in a murine model of allergic asthma. We evaluated the presence of flagellin activity in house dust of asthma patients. Finally, we analyzed the association of a dominant-negative polymorphism in TLR5 (rs5744168) with asthma symptoms in patients with asthma.
We showed that bacterial flagellin can be found in the house dust of patients with asthma and that this bacterial product exacerbates allergic airway inflammation in an allergen-specific mouse model of asthma. Furthermore, a dominant-negative genetic polymorphism in TLR5, the receptor for flagellin, is associated with decreased symptoms in patients with asthma.
Together, our results reveal a novel genetic protective factor (TLR5 deficiency) and a novel environmental pollutant (microbial flagellin) that influence asthma severity. (Clinical trials NCT01688986 and NCT01087307).
通过暴露于室内和室外污染物而引发的先天免疫激活,正成为影响哮喘严重程度的一个重要决定因素。例如,家庭环境中细菌产物脂多糖(LPS)的水平与哮喘严重程度增加有关。我们假设,细菌配体鞭毛蛋白激活先天免疫受体 TLR5 将加重气道炎症和哮喘症状。
我们在过敏性哮喘的小鼠模型中确定了鞭毛蛋白与卵清蛋白共同暴露的影响。我们评估了哮喘患者室内灰尘中鞭毛蛋白活性的存在。最后,我们分析了 TLR5(rs5744168)的显性负遗传多态性与哮喘患者哮喘症状之间的关联。
我们表明,细菌鞭毛蛋白可存在于哮喘患者的室内灰尘中,并且该细菌产物可加重变应原特异性哮喘小鼠模型中的过敏性气道炎症。此外,TLR5(鞭毛蛋白的受体)的显性负遗传多态性与哮喘患者的症状减轻有关。
总之,我们的研究结果揭示了一个新的遗传保护因子(TLR5 缺乏)和一个新的环境污染物(微生物鞭毛蛋白),它们影响哮喘的严重程度。(临床试验 NCT01688986 和 NCT01087307)。